[Clinical observation of Qanliexian decoction in the treatment of NIH III A prostatitis].
OBJECTIVE
To study the efficacy of Qianliexian Decoction in the treatment of National Institute of Health (NIH) III A prostatitis.


METHODS
Forty-six patients with NIH III A prostatitis were treated by oral Qianliexian Decoction 1 dose and twice a day for 30 days. The results of the treatment were evaluated according to the NIH chronic prostatitis symptom index (NIH-CPSI) and leukocyte counts in the expressed prostatic secretions (EPS).


RESULTS
The overall scores before and after the treatment were (32.3 +/- 7.4) and (17.8 +/- 4.2) on NIH-CPSI (P < 0.01), (13.2 +/- 3.6) and (7.8 +/- 2.3) on pain or discomfort (P < 0.01), (4.5 +/- 1.2) and (1.4 +/- 0.8) on urinary symptoms (P < 0.01), (14.6 +/- 7.4) and (8.6 +/- 3.5) on the quality of life (P < 0.01), and (20.6 +/- 2.4) /HP and (5.6 +/- 3.2)/HP on leukocyte counts, respectively. The decoction cured 8 of the patients and was shown to be obviously effective in 11 cases, effective in 20 and ineffective in 7, with a total efficacy rate of 84.78%.


CONCLUSIONS
Qianliexian Decoction is quite effective for the treatment of NIH III A prostatitis.
Huang
Jian
J
Department of Andrology, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, China. njnjhj@yahoo.com.cn
D000328:Adult; D002908:Chronic Disease; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D011472:Prostatitis / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D004365:Drugs, Chinese Herbal; C528820:qanliexian